It’s About Removing a Recognized Risk…

One of the most common problems with biopsy handling is the risk of being exposed to formalin and formaldehyde either through touch or inhalation. The IARC, which is the Cancer Agency of the World Health Organization, classifies formaldehyde as a category 1b carcinogen. * Suited to a wide range of biopsy procedures, BiopSafe offers the same quality sample fixation you’re used to, but with additional safety.

Data and Studies

FORMALIN EXPOSURE: A Review of Known Health Hazards and the Role of Innovation in Improving Safety

In studies stretching back several decades, exposure to formaldehyde, the main ingredient in formalin, has been linked to respiratory tract and skin irritation after immediate exposure. Long-term formaldehyde exposure has also been shown to increase the risk for developing nasopharyngeal cancer, sinonasal cancer, and myeloid leukemia. Read Merit’s recently published white paper regarding the risk of formaldehyde exposure and the innovations helping to reduce that risk.

2018 Innovative Technology Designation


BiopSafe® smart system has received a 2018 Innovative Technology designation from Vizient, Inc. Read the Press Release >

Product Benefits:

  • Safe sample handling with no exposure to formalin or formaldehyde via touch or inhalation
  • Ready in seconds
  • No sensory irritation
  • Optimal formalin volumes minimize waste and expensive disposal costs

View Fullscreen

Catalog NumberExpanded Family NameVolume (m L)FluidActive IngredientSterilizationLatex FreeShipping Box Qty
3178-200-00Sample Containment System20 mLFormalinFormaldehyde 4%NSYes24
3178-600-00Sample Containment System60 mLFormalinFormaldehyde 4%NSYes18